To identify the role of MMP14 in the development of lung fibrosis, Sftpc-Mmp14-cKO and control mice were treated with a single intratracheal injection of bleomycin and evaluated at two time-points, 21 and 120 days that represents the fibrosis and resolution phases. The gene discussed is SFTPC; the disease is pulmonary fibrosis.